Granutec Acquisition Gives Leiner Strong Private Label OTC Position
This article was originally published in The Tan Sheet
Executive Summary
Leiner Health Products' acquisition of Granutec and Stanley Pharmaceuticals for approximately $60.1 mil., announced as completed Dec. 21, makes Leiner the leading supplier of private label "self-care products" in the U.S., the company said.